Skip to content

Mirum Pharmaceuticals, Inc. MIRM Professional service fees

Professional service fees at other companies

Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Immunovant, Inc. logo
Immunovant, Inc.IMVT

Other financials

Income statement

See full
Revenue$159.9M+43.3%
Operating income-$789.5M-5,100%
Net income-$790.2M-5,284%
EPS (diluted)-$13.43-4,377%

Balance sheet

See full
Cash & equivalents$261.5M+43.5%
Total debt$13.5M+56.4%
Total equity$242.5M+4.0%
Total assets$890.9M+29.1%

Cash flow

See full
Operating cash flow-$228.8M-11,566%
CapEx$664.0K+1,520%
Free cash flow-$229.4M-11,360%

Valuation

See full
Market cap$6.53B+152%
Enterprise value$6.28B+162%
P/S11.5×+4.6×

Profitability

See full
Operating margin-139.8%-168pp
Net margin-140.2%-169pp
FCF margin-30.3%

Returns & leverage

See full
Return on equity-335.8%-377pp
Debt / equity0.1×0.0×
Current ratio2.1×-1.1×

Where this comes from

Reported directly by Mirum Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccruedProfessionalFeesCurrent.

The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mirum Pharmaceuticals, Inc.'s professional service fees.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mirum Pharmaceuticals, Inc.'s professional service fees?
Mirum Pharmaceuticals, Inc. (MIRM) reported professional service fees of $22.58M in Q1 2026.
How has Mirum Pharmaceuticals, Inc.'s professional service fees changed year-over-year?
Mirum Pharmaceuticals, Inc.'s professional service fees increased by 61.6% year-over-year, from $13.97M to $22.58M.
What is the long-term trend for Mirum Pharmaceuticals, Inc.'s professional service fees?
Over 2 years (2023 to 2025), Mirum Pharmaceuticals, Inc.'s professional service fees has grown at a 47.6% compound annual growth rate (CAGR), from $7.94M to $17.29M.